|
Volumn 28, Issue 1, 2013, Pages 6-8
|
Retreatment by antithymocyte globulin for second kidney transplantation: Efficacy, tolerance and safety
|
Author keywords
Depletion; Induction; Post transplantation lymphoproliferative disease; Rabbit antithymocyte globulin; Retransplantation
|
Indexed keywords
THYMOCYTE ANTIBODY;
VALGANCICLOVIR;
ACUTE GRAFT REJECTION;
ADULT;
ARTICLE;
CASE CONTROL STUDY;
CONTROLLED STUDY;
CYTOMEGALOVIRUS INFECTION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FEMALE;
FOLLOW UP;
HUMAN;
KIDNEY TRANSPLANTATION;
LEUKOCYTE COUNT;
LYMPHOCYTE COUNT;
LYMPHOCYTE DEPLETION;
MAINTENANCE THERAPY;
MAJOR CLINICAL STUDY;
MALE;
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE;
PRIORITY JOURNAL;
RETREATMENT;
RETROSPECTIVE STUDY;
SIDE EFFECT;
THROMBOCYTE COUNT;
VIRUS REACTIVATION;
ADULT;
ANTILYMPHOCYTE SERUM;
CASE-CONTROL STUDIES;
CYTOMEGALOVIRUS;
CYTOMEGALOVIRUS INFECTIONS;
FEMALE;
FOLLOW-UP STUDIES;
GRAFT REJECTION;
HUMANS;
INCIDENCE;
KIDNEY TRANSPLANTATION;
LYMPHOPROLIFERATIVE DISORDERS;
MALE;
MIDDLE AGED;
POSTOPERATIVE COMPLICATIONS;
RETROSPECTIVE STUDIES;
VIRUS ACTIVATION;
|
EID: 84873056180
PISSN: 09663274
EISSN: 18785492
Source Type: Journal
DOI: 10.1016/j.trim.2012.11.008 Document Type: Article |
Times cited : (5)
|
References (4)
|